[Form 4] Affirm Holdings, Inc. Insider Trading Activity
Max Levchin, CEO and director of Affirm Holdings, reported transactions on Form 4 showing he sold 167,443 shares of Class A common stock on 08/22/2025 at a weighted average price of $80.10 per share under a Rule 10b5-1 trading plan adopted March 17, 2025. The sale reduced his direct holdings of the reported tranche to 0 shares, while he continues to be listed as an indirect holder of 735,294 shares through the Levchin 2012 Irrevocable Trust. The filing also discloses that Levchin has 4,000,000 earned and vested performance-based stock options from a 2021 grant, and total beneficial ownership reported after transactions is 12,317,604 shares.
- Transaction executed under a Rule 10b5-1 plan, providing an affirmative defense and indicating pre-planned liquidity
- Disclosure includes trust and option details, improving transparency about indirect holdings and vested options
- None.
Insights
TL;DR Insider sold 167,443 shares under a pre-established 10b5-1 plan; retains material indirect and option positions.
The sale appears to be an orderly disposition executed under a Rule 10b5-1 plan, which provides an affirmative defense against insider trading claims when properly adopted. The transaction reduced Levchin's direct reported Class A holdings by 167,443 shares at a weighted average sale price of $80.10. He still has substantial economic exposure via 735,294 shares held indirectly in a family trust and 4,000,000 vested performance options, leaving overall alignment with shareholder outcomes intact. This is a routine liquidity event rather than a change in control or governance.
TL;DR Governance impact is limited; disclosure follows Rule 10b5-1 practice and includes trust disclaimers.
The Form 4 includes the customary disclosure that the Levchin 2012 Irrevocable Trust shares are reported as indirect and that Levchin disclaims beneficial ownership except to the extent of pecuniary interest. The use of an attorney-in-fact signature and explicit footnotes about the 10b5-1 plan and option tranche vesting provide clear auditability. From a governance standpoint, no officer resignation, repricing, or unusual transfer is indicated, so material governance risk is not evident.